GBA1 and Parkinson disease: Considering that the vast majority of PD-GBA1 treated with DBS, as reported in the literature, received chronic electrical stimulation of bilateral STN and given the supposed ‘cognitively safer’ action of GPi-DBS, it seems an urgent need to obtain data from PD-GBA1 treated with GPi-DBS.